NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 56 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,665,000 | -57.8% | 1,250,000 | -58.3% | 0.00% | -50.0% |
| Q1 2022 | $3,945,000 | -29.5% | 3,000,000 | -33.3% | 0.01% | -25.0% |
| Q4 2021 | $5,593,000 | -6.7% | 4,500,000 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $5,995,000 | +0.3% | 4,500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $5,980,000 | -2.0% | 4,500,000 | 0.0% | 0.01% | -9.1% |
| Q1 2021 | $6,100,000 | -11.6% | 4,500,000 | -10.0% | 0.01% | -26.7% |
| Q4 2020 | $6,904,000 | +0.2% | 5,000,000 | 0.0% | 0.02% | -11.8% |
| Q3 2020 | $6,893,000 | +18.6% | 5,000,000 | +42.9% | 0.02% | +6.2% |
| Q2 2020 | $5,810,000 | +21.4% | 3,500,000 | -6.7% | 0.02% | 0.0% |
| Q1 2020 | $4,787,000 | -3.6% | 3,750,000 | +15.4% | 0.02% | +23.1% |
| Q4 2019 | $4,964,000 | -44.3% | 3,250,000 | -50.0% | 0.01% | -51.9% |
| Q3 2019 | $8,918,000 | -20.4% | 6,500,000 | -23.5% | 0.03% | -22.9% |
| Q2 2019 | $11,208,000 | +10.4% | 8,500,000 | +13.3% | 0.04% | +6.1% |
| Q1 2019 | $10,155,000 | +93.8% | 7,500,000 | +66.7% | 0.03% | +65.0% |
| Q4 2018 | $5,240,000 | +11.7% | 4,500,000 | +63.6% | 0.02% | +17.6% |
| Q3 2018 | $4,693,000 | -28.3% | 2,750,000 | -38.9% | 0.02% | -29.2% |
| Q2 2018 | $6,549,000 | – | 4,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 45,447,000 | $60,497,000 | 1.31% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,366,000 | $5,924,000 | 0.54% |
| Aequim Alternative Investments LP | 7,609,000 | $10,088,000 | 0.43% |
| MACKAY SHIELDS LLC | 27,806,000 | $37,405,000 | 0.35% |
| Weiss Asset Management LP | 10,000,000 | $13,290,000 | 0.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 13,230,000 | $17,541,000 | 0.13% |
| Polar Asset Management Partners Inc. | 7,500,000 | $9,942,000 | 0.10% |
| LORD, ABBETT & CO. LLC | 22,141,000 | $29,732,000 | 0.07% |
| Calamos Advisors LLC | 7,500,000 | $9,967,000 | 0.05% |
| D. E. Shaw & Co., Inc. | 39,270,000 | $52,046,000 | 0.04% |